Lm. Luttrell et al., Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds, P NAS US, 98(5), 2001, pp. 2449-2454
Citations number
34
Categorie Soggetti
Multidisciplinary
Journal title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Using both confocal immunofluorescence microscopy and biochemical approache
s, we have examined the role of beta -arrestins in the activation and targe
ting of extracellular signal-regulated kinase 2 (ERK2) following stimulatio
n of angiotensin II type 1a receptors (AT1aR). In HEK-293 cells expressing
hemagglutinin-tagged AT1aR, angiotensin stimulation triggered beta -arresti
n-2 binding to the receptor and internalization of AT1aR-beta -arrestin com
plexes. Using red fluorescent protein-tagged ERK2 to track the subcellular
distribution of ERK2, we found that angiotensin treatment caused the redist
ribution of activated ERK2 into endosomal vesicles that also contained AT1a
R-beta -arrestin complexes. This targeting of ERK2 reflects the formation o
f multiprotein complexes containing AT1aR, beta -arrestin-2, and the compon
ent kinases of the ERK cascade, cRaf-1, MEK1, and ERK2. Myc-tagged cRaf-1,
MEK1, and green fluorescent protein-tagged ERK2 coprecipitated with Flag-ta
gged beta -arrestin-2 from transfected COS-7 cells. Coprecipitation of cRaf
-1 with beta -arrestin-2 was independent of MEK1 and ERK2, whereas the copr
ecipitation of MEK1 and ERK2 with beta -arrestin-2 was significantly enhanc
ed in the presence of overexpressed cRaf-1, suggesting that binding of cRaf
-1 to beta -arrestin facilitates the assembly of a cRaf-1, MEK1, ERK2 compl
ex. The phosphorylation of ERK2 in beta -arrestin complexes was markedly en
hanced by coexpression of cRaf-1, and this effect is blocked by expression
of a catalytically inactive dominant inhibitory mutant of MEK1. Stimulation
with angiotensin increased the binding of both cRaf-1 and ERK2 to beta -ar
restin-2, and the association of beta -arrestin-2, cRaf-1, and ERK2 with AT
1aR. These data suggest that beta -arrestins function both as scaffolds to
enhance cRaf-1 and MEK-dependent activation of ERK2, and as targeting prote
ins that direct activated ERK to specific subcellular locations.